Lymphoma and leukemia are types of cancer that affect the blood cells, bone marrow, lymph nodes and the lymphatic system. With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment tailored to your specific cancer type.
Carle Cancer Institute offers premier cancer treatment and support services at our locations throughout central Illinois, offering more resources to help patients in the fight against cancer. With our specialized team of fellowship trained oncologists, surgeons and staff, patients get in for diagnosis and start treatment as soon as possible.FIND A DOCTOR VISIT INSTITUTE
Multidisciplinary Care Approach
Our team includes experts in:
Lymphoma and Leukemia Treatment Options
Hematological malignancies are cancers that begin in blood-forming tissue, such as in the bone marrow or in the cells of the immune system.
Examples of hematologic cancer are leukemia, lymphoma, and multiple myeloma, also called blood cancer. Various hematological malignancies may occur. The most common types include:
HEMOTHERAPY FOR HEMATOLOGICAL MALIGNANCIES
Anticancer drugs given by IV injection or taken by mouth enter the bloodstream and affect cells in most parts of the body. However, the drugs often do not reach cells in the central nervous system because they are stopped by the blood-brain barrier. This protective barrier is formed by a network of blood vessels that filter blood going to the brain and spinal cord. To reach cells in the central nervous system, doctors may use intrathecal chemotherapy. In this type of leukemia treatment, anticancer drugs are injected directly into the cerebrospinal fluid.
Chemotherapy is usually given in cycles. Periods of chemotherapy treatment are alternated with rest periods when no chemotherapy is given. Chemotherapy may be administered in a single day, over the course of days to weeks to months. The frequency of chemotherapy depends largely on the type of cancer and type of drug or drugs being given. The length of time for chemotherapy is based on evidence guidelines, response to treatment and side effects.
Common drugs given for hematological cancers include biological modifiers, antineoplastic drugs and targeted therapy.
Side effects from treatment can be well controlled and may include hair loss, constipation, diarrhea, fatigue, appetite changes, nausea or vomiting, and decreased blood counts.
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.